Back to results
Active, not recruitingPhase 1

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

NCT04432857

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Washington University School of Medicine - Siteman Cancer Center

St Louis, Missouri, United States

+5 additional locations

View on ClinicalTrials.gov
AN0025 and Pembrolizumab Combination in Advanced Solid Tumors — TrialFind